REFERENCES
1. Li Y, Guo Z, Xu T, et al. Extracellular vesicles, a novel model linking bacteria to ferroptosis in the future? Appl Microbiol Biotechnol. 2022;106:7377-86.
2. Palomino RA, Vanpouille C, Costantini PE, Margolis L. Microbiota-host communications: bacterial extracellular vesicles as a common language. PLoS Pathog. 2021;17:e1009508.
3. Dagnelie MA, Corvec S, Khammari A, Dréno B. Bacterial extracellular vesicles: a new way to decipher host-microbiota communications in inflammatory dermatoses. Exp Dermatol. 2020;29:22-8.
4. der Pol L, Stork M, van der Ley P. Outer membrane vesicles as platform vaccine technology. Biotechnol J. 2015;10:1689-706.
5. Li M, Zhou H, Yang C, et al. Bacterial outer membrane vesicles as a platform for biomedical applications: an update. J Control Release. 2020;323:253-68.
6. Huang W, Meng L, Chen Y, Dong Z, Peng Q. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy. Acta Biomater. 2022;140:102-15.
7. Nally JE, Whitelegge JP, Aguilera R, Pereira MM, Blanco DR, Lovett MA. Purification and proteomic analysis of outer membrane vesicles from a clinical isolate of leptospira interrogans serovar copenhageni. Proteomics. 2005;5:144-52.
8. Brennan K, Martin K, FitzGerald SP, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep. 2020;10:1039.
9. Zhu Z, Antenucci F, Villumsen KR, Bojesen AM. Bacterial outer membrane vesicles as a versatile tool in vaccine research and the fight against antimicrobial resistance. mBio. 2021;12:e0170721.
10. Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347.
11. Merchant ML, Powell DW, Wilkey DW, et al. Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin Appl. 2010;4:84-96.
12. Lobb RJ, Becker M, Wen SW, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031.
13. Zhang Q, Jeppesen DK, Higginbotham JN, Franklin JL, Coffey RJ. Comprehensive isolation of extracellular vesicles and nanoparticles. Nat Protoc. 2023;18:1462-87.
14. Aytar Çelik P, Derkuş B, Erdoğan K, et al. Bacterial membrane vesicle functions, laboratory methods, and applications. Biotechnol Adv. 2022;54:107869.
15. Castillo-Romero KF, Santacruz A, González-Valdez J. Production and purification of bacterial membrane vesicles for biotechnology applications: challenges and opportunities. Electrophoresis. 2023;44:107-24.
16. Gardiner C, Di Vizio D, Sahoo S, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5:32945.
17. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
18. Chutkan H, Macdonald I, Manning A, Kuehn MJ. Quantitative and qualitative preparations of bacterial outer membrane vesicles. In: Delcour AH, Editor. Bacterial Cell Surfaces. Totowa: Humana Press; 2013. pp. 259-72.
19. Ford T, Graham J, Rickwood D. Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients. Anal Biochem. 1994;220:360-6.
20. Huang Y, Wang S, Cai Q, Jin H. Effective methods for isolation and purification of extracellular vesicles from plants. J Integr Plant Biol. 2021;63:2020-30.
21. Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option? Int J Mol Sci. 2020;21:6466.
22. Koliha N, Wiencek Y, Heider U, et al. A novel multiplex bead-based platform highlights the diversity of extracellular vesicles. J Extracell Vesicles. 2016;5:29975.
23. Reiner AT, Witwer KW, van Balkom BWM, et al. Concise review: developing best-practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med. 2017;6:1730-9.
24. Cheng S, Li Y, Yan H, et al. Advances in microfluidic extracellular vesicle analysis for cancer diagnostics. Lab Chip. 2021;21:3219-43.
25. Omrani M, Beyrampour-Basmenj H, Jahanban-Esfahlan R, et al. Global trend in exosome isolation and application: an update concept in management of diseases. Mol Cell Biochem. 2024;479:679-91.
26. Gholizadeh S, Shehata Draz M, Zarghooni M, et al. Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: current status and future directions. Biosens Bioelectron. 2017;91:588-605.
27. Havers M, Broman A, Lenshof A, Laurell T. Advancement and obstacles in microfluidics-based isolation of extracellular vesicles. Anal Bioanal Chem. 2023;415:1265-85.
28. Sangiorgio G, Nicitra E, Bivona D, et al. Interactions of Gram-positive bacterial membrane vesicles and hosts: updates and future directions. Int J Mol Sci. 2024;25:2904.
29. Xu Y, Xie C, Liu Y, Qin X, Liu J. An update on our understanding of Gram-positive bacterial membrane vesicles: discovery, functions, and applications. Front Cell Infect Microbiol. 2023;13:1273813.
30. Kurata A, Kiyohara S, Imai T, et al. Characterization of extracellular vesicles from Lactiplantibacillus plantarum. Sci Rep. 2022;12:13330.
31. Li Z, Li M, Fang X, Yu D, Hu X. Dietary Lactobacillus johnsonii-derived extracellular vesicles ameliorate acute colitis by regulating gut microbiota and maintaining intestinal barrier homeostasis. Food Funct. 2024;15:11757-79.
32. Zhu R, Zhang Y, Wang X, et al. Probiotic bacteria-released extracellular vesicles enhance macrophage phagocytosis in polymicrobial sepsis by activating the FPR1/2 pathway. Mol Med. 2024;30:216.
33. Mehanny M, Kroniger T, Koch M, et al. Yields and immunomodulatory effects of pneumococcal membrane vesicles differ with the bacterial growth phase. Adv Healthc Mater. 2022;11:e2101151.
34. Bitto NJ, Cheng L, Johnston EL, et al. Staphylococcus aureus membrane vesicles contain immunostimulatory DNA, RNA and peptidoglycan that activate innate immune receptors and induce autophagy. J Extracell Vesicles. 2021;10:e12080.
35. Narciso AR, Aschtgen M. Strategies to isolate extracellular vesicles from Gram-negative and Gram-positive bacteria. In: Nordenfelt P, Collin M, Editors. Bacterial Pathogenesis. New York: Springer US; 2023. pp. 61-70.
36. Micoli F, Adamo R, Nakakana U. Outer membrane vesicle vaccine platforms. BioDrugs. 2024;38:47-59.
37. Watson DC, Johnson S, Santos A, et al. Scalable isolation and purification of extracellular vesicles from escherichia coli and other bacteria. J Vis Exp. 2021;176:10.3791/63155.
38. Liu H, Zhang H, Han Y, Hu Y, Geng Z, Su J. Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy. Theranostics. 2022;12:6576-94.
39. Lei Q, Divakarla SK, Winsley T, Roux S, Chrzanowski W. Bioprocessing strategies for enhanced probiotic extracellular vesicle production: culture condition modulation. Front Bioeng Biotechnol. 2024;12:1441552.
40. Hernández-Díazcouder A, Díaz-Godínez C, Carrero JC. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update. Appl Microbiol Biotechnol. 2023;107:2131-41.
41. Peregrino ES, Castañeda-Casimiro J, Vázquez-Flores L, et al. The role of bacterial extracellular vesicles in the immune response to pathogens, and therapeutic opportunities. Int J Mol Sci. 2024;25:6210.
43. Parveen S, Subramanian K. Emerging roles of extracellular vesicles in pneumococcal infections: immunomodulators to potential novel vaccine candidates. Front Cell Infect Microbiol. 2022;12:836070.
44. Kim W, Lee EJ, Bae IH, et al. Lactobacillus plantarum-derived extracellular vesicles induce anti-inflammatory M2 macrophage polarization in vitro. J Extracell Vesicles. 2020;9:1793514.
45. Koeppen K, Hampton TH, Jarek M, et al. A novel mechanism of host-pathogen interaction through sRNA in bacterial outer membrane vesicles. PLoS Pathog. 2016;12:e1005672.
46. Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6:291.
47. Doré E, Boilard E. Bacterial extracellular vesicles and their interplay with the immune system. Pharmacol Ther. 2023;247:108443.
48. Aytar Çelik P, Erdogan-Gover K, Barut D, et al. Bacterial membrane vesicles as smart drug delivery and carrier systems: a new nanosystems tool for current anticancer and antimicrobial therapy. Pharmaceutics. 2023;15:1052.
49. Gnopo YMD, Watkins HC, Stevenson TC, DeLisa MP, Putnam D. Designer outer membrane vesicles as immunomodulatory systems - reprogramming bacteria for vaccine delivery. Adv Drug Deliv Rev. 2017;114:132-42.
50. Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, O'Toole GA, Stanton BA. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 2009;5:e1000382.
51. Gao J, Wang S, Dong X, Wang Z. RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting. Theranostics. 2021;11:3301-16.
52. Kuerban K, Gao X, Zhang H, et al. Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer. Acta Pharm Sin B. 2020;10:1534-48.
53. Alaniz RC, Deatherage BL, Lara JC, Cookson BT. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol. 2007;179:7692-701.
54. Zheng K, Feng Y, Li L, Kong F, Gao J, Kong X. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors. Theranostics. 2024;14:761-87.
55. D'Acunzo P, Kim Y, Ungania JM, Pérez-González R, Goulbourne CN, Levy E. Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues. Nat Protoc. 2022;17:2517-49.
56. Ramasubramanian L, Kumar P, Wang A. Engineering extracellular vesicles as nanotherapeutics for regenerative medicine. Biomolecules. 2019;10:48.
57. Matsuzaka Y, Yashiro R. Advances in purification, modification, and application of extracellular vesicles for novel clinical treatments. Membranes. 2022;12:1244.
58. Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178:113961.
59. Zheng X, Ai H, Qian K, et al. Small extracellular vesicles purification and scale-up. Front Immunol. 2024;15:1344681.
60. Kowkabany G, Bao Y. Nanoparticle tracking analysis: an effective tool to characterize extracellular vesicles. Molecules. 2024;29:4672.
61. Florez C, Raab JE, Cooke AC, Schertzer JW. Membrane distribution of the pseudomonas quinolone signal modulates outer membrane vesicle production in pseudomonas aeruginosa. mBio. 2017;8:e01034-17.
62. Macdonald IA, Kuehn MJ. Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa. J Bacteriol. 2013;195:2971-81.
63. Tashiro Y, Ichikawa S, Shimizu M, et al. Variation of physiochemical properties and cell association activity of membrane vesicles with growth phase in Pseudomonas aeruginosa. Appl Environ Microbiol. 2010;76:3732-9.
64. Naradasu D, Miran W, Sharma S, et al. Biogenesis of outer membrane vesicles concentrates the unsaturated fatty acid of phosphatidylinositol in capnocytophaga ochracea. Front Microbiol. 2021;12:682685.
65. Ma G, Ding Y, Wu Q, et al. Yersinia enterocolitica-derived outer membrane vesicles inhibit initial stage of biofilm formation. Microorganisms. 2022;10:2357.
66. Sartorio MG, Pardue EJ, Feldman MF, Haurat MF. Bacterial outer membrane vesicles: from discovery to applications. Annu Rev Microbiol. 2021;75:609-30.
67. Gnopo YMD, Misra A, Hsu HL, DeLisa MP, Daniel S, Putnam D. Induced fusion and aggregation of bacterial outer membrane vesicles: experimental and theoretical analysis. J Colloid Interface Sci. 2020;578:522-32.
68. Lynch JB, Schwartzman JA, Bennett BD, et al. Ambient pH alters the protein content of outer membrane vesicles, driving host development in a beneficial symbiosis. J Bacteriol. 2019;201:e00319-19.
69. Roier S, Zingl FG, Cakar F, et al. A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria. Nat Commun. 2016;7:10515.
70. Tsolakos N, Lie K, Bolstad K, et al. Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media. Vaccine. 2010;28:3211-8.
71. McCaig WD, Loving CL, Hughes HR, Brockmeier SL. Characterization and vaccine potential of outer membrane vesicles produced by haemophilus parasuis. PLoS One. 2016;11:e0149132.
72. Klimentová J, Stulík J. Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria. Microbiol Res. 2015;170:1-9.
73. Płaczkiewicz J, Gieczewska K, Musiałowski M, Adamczyk-Popławska M, Bącal P, Kwiatek A. Availability of iron ions impacts physicochemical properties and proteome of outer membrane vesicles released by Neisseria gonorrhoeae. Sci Rep. 2023;13:18733.
74. Sinha A, Nyongesa S, Viau C, Gruenheid S, Veyrier FJ, Le Moual H. PmrC (EptA) and CptA negatively affect outer membrane vesicle production in Citrobacter rodentium. J Bacteriol. 2019;201:e00454-18.
75. Olczak T, Wójtowicz H, Ciuraszkiewicz J, Olczak M. Species specificity, surface exposure, protein expression, immunogenicity, and participation in biofilm formation of Porphyromonas gingivalis HmuY. BMC Microbiol. 2010;10:134.
76. Gorringe A, Halliwell D, Matheson M, Reddin K, Finney M, Hudson M. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Vaccine. 2005;23:2210-3.
77. Kintz E, Goldberg JB. Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa. Future Microbiol. 2008;3:191-203.
78. Cairns CM, Michael FS, Jamshidi M, et al. Structural characterization and evaluation of an epitope at the tip of the A-band rhamnan polysaccharide of Pseudomonas aeruginosa. ACS Infect Dis. 2022;8:1336-46.
79. van de Waterbeemd B, Zomer G, van den Ijssel J, et al. Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development. PLoS One. 2013;8:e54314.
80. Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev. 2022;185:114294.
81. David L, Taieb F, Pénary M, et al. Outer membrane vesicles produced by pathogenic strains of Escherichia coli block autophagic flux and exacerbate inflammasome activation. Autophagy. 2022;18:2913-25.
